Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)

The summary for the Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20): -This solicitation invites applications for the development of Exploratory Translational Research Centers on the clinical neurobiology of drug abuse and addiction. For purposes of this RFA, an Exploratory Translational Research Center is defined as an entity with a strong primary human neurobiology focus in which preclinical research is included to directly inform or provide a mechanistic foundation for the human neuroscience/neurobiologic research. -NIDA intends to commit $2.5 million dollars in FY2008 to fund 2-3 new grants in response to this RFA. Applicants may request support for only one period of up to four years; direct costs requested may not exceed $600,000 in any one year. -This RFA will use the NIH P20 award mechanism. The P20 is a planning grant mechanism to promote the development of mature translational research centers by the end of the funding period. The focus of these applications should be on the development of appropriate infrastructure, including personnel and resources, and the generation of sufficient high quality data to provide the basis for a mature P50 translational research center application by the end of the funding period.

Federal Grant Title:	Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Education
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DA-08-022
Type of Funding:	Grant
CFDA Numbers:	93.279
CFDA Descriptions:	Drug Abuse and Addiction Research Programs
Current Application Deadline:	No deadline provided
Original Application Deadline:	Feb 27, 2008
Posted Date:	Dec 10, 2007
Creation Date:	Dec 12, 2007
Archive Date:	Apr 13, 2008
Total Program Funding:	$2,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education City or township governments Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research...; • Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG...; • Single Source: National Longitudinal Study of Adolescent to Adult (Add) Health Wave VII (U...; • Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and P...; • Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Tri...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34); • Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic ...; • Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional); • Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Train...